Serum sRAGE levels in children with atopic dermatitis: a prospective study

Hatice Eke-Gungor1, Bilal Sagiroglu2, Zehra Nur Can-Coskun3

  • 1Department of Paediatric Allergy and Immunology, University of Health Sciences, Kayseri City Training and Research Hospital, Kayseri, Turkey.

PubMed
Summary

Serum soluble receptor for advanced glycation end products (sRAGE) levels are lower in children with atopic dermatitis (AD). This finding suggests sRAGE may play a role in AD pathogenesis.

Related Concept Videos